226 related articles for article (PubMed ID: 17059464)
1. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells.
Falguières T; Römer W; Amessou M; Afonso C; Wolf C; Tabet JC; Lamaze C; Johannes L
FEBS J; 2006 Nov; 273(22):5205-18. PubMed ID: 17059464
[TBL] [Abstract][Full Text] [Related]
2. The retromer component sorting nexin-1 is required for efficient retrograde transport of Shiga toxin from early endosome to the trans Golgi network.
Bujny MV; Popoff V; Johannes L; Cullen PJ
J Cell Sci; 2007 Jun; 120(Pt 12):2010-21. PubMed ID: 17550970
[TBL] [Abstract][Full Text] [Related]
3. Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect.
Lingwood CA; Binnington B; Manis A; Branch DR
FEBS Lett; 2010 May; 584(9):1879-86. PubMed ID: 19948172
[TBL] [Abstract][Full Text] [Related]
4. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
[TBL] [Abstract][Full Text] [Related]
5. Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells.
Takenouchi H; Kiyokawa N; Taguchi T; Matsui J; Katagiri YU; Okita H; Okuda K; Fujimoto J
J Cell Sci; 2004 Aug; 117(Pt 17):3911-22. PubMed ID: 15265987
[TBL] [Abstract][Full Text] [Related]
6. Polyunsaturated fatty acids regulate Shiga toxin transport.
Spilsberg B; Llorente A; Sandvig K
Biochem Biophys Res Commun; 2007 Dec; 364(2):283-8. PubMed ID: 17942073
[TBL] [Abstract][Full Text] [Related]
7. Identification of different itineraries and retromer components for endosome-to-Golgi transport of TGN38 and Shiga toxin.
Lieu ZZ; Gleeson PA
Eur J Cell Biol; 2010 May; 89(5):379-93. PubMed ID: 20138391
[TBL] [Abstract][Full Text] [Related]
8. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity.
Khine AA; Tam P; Nutikka A; Lingwood CA
Glycobiology; 2004 Aug; 14(8):701-12. PubMed ID: 15102715
[TBL] [Abstract][Full Text] [Related]
9. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic.
Arab S; Lingwood CA
J Cell Physiol; 1998 Dec; 177(4):646-60. PubMed ID: 10092217
[TBL] [Abstract][Full Text] [Related]
10. Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin.
Lauvrak SU; Torgersen ML; Sandvig K
J Cell Sci; 2004 May; 117(Pt 11):2321-31. PubMed ID: 15126632
[TBL] [Abstract][Full Text] [Related]
11. The epithelial cell cytoskeleton and intracellular trafficking. I. Shiga toxin B-subunit system: retrograde transport, intracellular vectorization, and more.
Johannes L
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G1-7. PubMed ID: 12065285
[TBL] [Abstract][Full Text] [Related]
12. SNX1 and SNX2 mediate retrograde transport of Shiga toxin.
Utskarpen A; Slagsvold HH; Dyve AB; Skånland SS; Sandvig K
Biochem Biophys Res Commun; 2007 Jun; 358(2):566-70. PubMed ID: 17498660
[TBL] [Abstract][Full Text] [Related]
13. Pathways followed by ricin and Shiga toxin into cells.
Sandvig K; Grimmer S; Lauvrak SU; Torgersen ML; Skretting G; van Deurs B; Iversen TG
Histochem Cell Biol; 2002 Feb; 117(2):131-41. PubMed ID: 11935289
[TBL] [Abstract][Full Text] [Related]
14. Endocytosis and retrograde transport of Shiga toxin.
Sandvig K; Bergan J; Dyve AB; Skotland T; Torgersen ML
Toxicon; 2010 Dec; 56(7):1181-5. PubMed ID: 19951719
[TBL] [Abstract][Full Text] [Related]
15. Globotriaosyl ceramide (Gb3) expression in human tumour cells: intracellular trafficking defines a new retrograde transport pathway from the cell surface to the nucleus, which correlates with sensitivity to verotoxin.
Lingwood CA; Khine AA; Arab S
Acta Biochim Pol; 1998; 45(2):351-9. PubMed ID: 9821866
[TBL] [Abstract][Full Text] [Related]
16. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.
Falguières T; Mallard F; Baron C; Hanau D; Lingwood C; Goud B; Salamero J; Johannes L
Mol Biol Cell; 2001 Aug; 12(8):2453-68. PubMed ID: 11514628
[TBL] [Abstract][Full Text] [Related]
17. Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin.
Raa H; Grimmer S; Schwudke D; Bergan J; Wälchli S; Skotland T; Shevchenko A; Sandvig K
Traffic; 2009 Jul; 10(7):868-82. PubMed ID: 19453975
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
19. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum.
Sandvig K; Garred O; Prydz K; Kozlov JV; Hansen SH; van Deurs B
Nature; 1992 Aug; 358(6386):510-2. PubMed ID: 1641040
[TBL] [Abstract][Full Text] [Related]
20. Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications.
Pina DG; Johannes L
Toxicon; 2005 Mar; 45(4):389-93. PubMed ID: 15733559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
